Advertisement · 728 × 90
#
Hashtag
#Atrialfibrillation
Advertisement · 728 × 90
Post image

Researchers reveal that Visinin-like protein 1 promotes #AtrialFibrillation by impairing calcium homeostasis via NCX-1, highlighting a novel molecular target for treating #CardiacArrhythmias.

#STTT #OpenAccess: doi.org/10.1038/s413...

0 0 0 0
Post image

AI-enabled handheld detection of AF recurrence after ablation.
www.scienceopen.com/hosted-docum...
#AtrialFibrillation #DeepLearning #DigitalHealth #CardioSky #MedSky

1 0 0 0
Preview
Study links atrial fibrillation to poorer brain clearance and cognitive decline Researchers found that people with atrial fibrillation had lower MRI-based glymphatic activity and poorer cognitive performance than healthy controls, with the greatest impairment seen in non-paroxysm...

AFib isn't just about the heart - new research reveals it may hamper the brain's waste-clearing system, linking it to cognitive decline. www.news-medical.net/news/2026033... #AtrialFibrillation #Neurology #CognitiveDecline @escardio.bsky.social

1 0 0 0
Preview
Atrial Fibrillation and Stroke Risk: Symptoms, Diagnosis, Blood Thinners and What Treatment Really Does | All Health and Care UK Atrial fibrillation explained for UK patients: symptoms, stroke risk, blood thinners, diagnosis, treatment options, and when to seek urgent help.

Atrial fibrillation can cause palpitations, breathlessness, dizziness, or tiredness — and it can also raise stroke risk.

Our guide explains symptoms, diagnosis, blood thinners and when to seek urgent help:
allhealthandcare.co.uk/resources/at...

#AtrialFibrillation #AFib #StrokePrevention

1 0 0 0
Redirecting

🫀 Just published online in JPS❣️
“Physiological doses of eicosapentaenoic acid suppress high-fat diet–induced atrial fibrillation in mice independent of lipid lowering”
— Kosuke Horii et al.
🔗 doi.org/10.1016/j.jp...
#AtrialFibrillation #EPA #CardiacProtection #Metabolism #NowOnline #JPhysiolSci

0 0 0 0
JAMA Cardiology article published online March 29, 2026, presents cumulative event-free survival curves stratified by serum neurofilament light chain (sNfL) quartiles (Qs) for major vascular events, nonfatal stroke, myocardial infarction and cardiovascular death.

JAMA Cardiology article published online March 29, 2026, presents cumulative event-free survival curves stratified by serum neurofilament light chain (sNfL) quartiles (Qs) for major vascular events, nonfatal stroke, myocardial infarction and cardiovascular death.

Among patients with #AtrialFibrillation, higher serum neurofilament light chain levels were associated with increased risk of major vascular events, stroke, cardiovascular death, and heart failure hospitalization.

#ACC2026 @accintouch.bsky.social

ja.ma/3O4Tkmk

1 1 0 0
Post image

Predictors & impact of early AF recurrence after RF ablation.
www.scienceopen.com/hosted-docum...
#AtrialFibrillation #Ablation #Outcomes #CardioSky #MedSky

0 0 0 0
Post image

Adipokines contribute to AF pathophysiology.
www.scienceopen.com/hosted-docum...
#AtrialFibrillation #Adipokines #Pathophysiology #CardioSky #MedSky

0 0 0 0
Post image

Serum uric acid associated with AF burden.
www.scienceopen.com/hosted-docum...
#AtrialFibrillation #UricAcid #Risk #CardioSky #MedSky

0 0 0 0
Post image

Catheter ablation as first-line therapy for AF—clinical implications.
www.scienceopen.com/hosted-docum...
#AtrialFibrillation #CatheterAblation #Arrhythmia #CardioSky #MedSky

1 1 0 0
Post image

Atrial fibrillation & electrophysiology in CVIA—mechanisms, biomarkers & ablation advances.
cvia-journal.org
#AtrialFibrillation #Electrophysiology #Cardiology #CardioSky #MedSky

2 0 8 0
CRNM Bleeding for Abelacimab vs Rivaroxaban. Graph A shows bleeding rates per 100 patient-years stratified by age. Graph B shows probability of major/CRNM bleeding at text@2.3y. The rivaroxaban probability rises with age, while abelacimab remains stable.

CRNM Bleeding for Abelacimab vs Rivaroxaban. Graph A shows bleeding rates per 100 patient-years stratified by age. Graph B shows probability of major/CRNM bleeding at text@2.3y. The rivaroxaban probability rises with age, while abelacimab remains stable.

Among older patients with #AtrialFibrillation, abelacimab reduced major or clinically relevant bleeding vs rivaroxaban, with a greater absolute risk reduction in those aged ≥75 years. ja.ma/3ZZ0T0i

1 0 0 0
The forest plot displays hazard ratios (aHR) with 95% confidence intervals for age and cardiovascular mortality. aHR decreases with age, starting at 0.66 for ages 70+ down to 0.73 for 80+. Cardiovascular mortality also decreases, from 0.52 for 70+ to 0.51 for 80+.

The forest plot displays hazard ratios (aHR) with 95% confidence intervals for age and cardiovascular mortality. aHR decreases with age, starting at 0.66 for ages 70+ down to 0.73 for 80+. Cardiovascular mortality also decreases, from 0.52 for 70+ to 0.51 for 80+.

A village doctor-led, telemedicine-supported model improved cardiovascular outcomes and ABC pathway adherence in rural patients aged 75 years or older with #AtrialFibrillation compared with usual care. ja.ma/4uwtWXa

0 0 0 0
Post image

#AF + increase in HAS-BLED score and OAC discontinuation ⬇️

📌 Rungpradubvong et al. (COOL-AF): OAC discontinuation → ⬆️ mortality (aHR 3.66) & major bleeding (aHR 2.60)

📌 ⬆️ HAS-BLED = optimize risk, not stop OAC

👉 www.thieme-connect.de/products/ejo...

#CardioSky #AtrialFibrillation

1 0 1 0
JAMA Neurology graphic detailing an RCT on catheter ablation and oral anticoagulation for secondary stroke prevention in atrial fibrillation. Key points: Population (187 men, 62 women, mean age 71.7y), Intervention (249 patients), and Findings(no significant difference).

JAMA Neurology graphic detailing an RCT on catheter ablation and oral anticoagulation for secondary stroke prevention in atrial fibrillation. Key points: Population (187 men, 62 women, mean age 71.7y), Intervention (249 patients), and Findings(no significant difference).

In patients with #AtrialFibrillation and recent #stroke, adding catheter ablation to oral anticoagulation did not significantly reduce recurrent stroke, systemic embolism, death, or hospitalization for heart failure compared to standard therapy.

ja.ma/4ui1isp

0 0 0 0
Post image

Final reminder.
The iCARDIO AF Survey closes tomorrow, 8 March.

Share your real-world insights on AF diagnosis, anticoagulation uptake, and #StrokePrevention across healthcare systems.

Submit before the deadline:
icardioalliance.org/surveys/

#AtrialFibrillation #Cardiology #iCARDIO

0 0 0 0
Post image

The iCARDIO Atrial Fibrillation (AF) Survey closes 8 March.
Share your real-world insights on AF diagnosis, anticoagulation, stroke prevention, and care barriers.

Submit before the deadline:
icardioalliance.org/surveys/

#AtrialFibrillation #Cardiology #StrokePrevention #iCARDIO

1 0 1 0
Preview
Exploring a new risk mechanism linking anxiety/behaviour and cardiac arrhythmias: a multidisciplinary, cross-species, approach at Cardiff University on FindAPhD.com PhD Project - Exploring a new risk mechanism linking anxiety/behaviour and cardiac arrhythmias: a multidisciplinary, cross-species, approach at Cardiff University, listed on FindAPhD.com

Last chance to apply for our #PhD position for UK/EU students @cardiffuni.bsky.social investigating how steroid sulfatase deficiency results in increased #arrhythmia #atrialfibrillation risk #cardiology #psychology www.findaphd.com/phds/project...

0 0 0 1
Preview
Contemporary management of atrial fibrillation in patients with cancer—the 2025 European Heart Rhythm Association survey AbstractAims. This study aimed to assess current clinical practices in the diagnosis and management of atrial fibrillation (AF) among patients with active

📰 BREAKING NEWS 📰

The European Heart Rhythm Association has released their 2025 survey on how atrial fibrillation (AF) is being treated in cancer patients and survivors.

Read the study: academic.oup.com/europace/art...

#cardioonc #cardiooncology #cardiology #atrialfibrillation

0 0 0 0

1/
I developed #AtrialFibrillation as a consequence of #LongCOVID. My heart rate could reach 250bpm, while just sitting -

6 2 2 0

My #LongCOVID heart rate could get up to 250bpm just sitting still. It took 4 years & an episode of #AtrialFibrillation at #Whitehorse ER, before I got a prescription for beta blockers. Until then, my family doc referred me to a supervised exercise programme, while "waiting & seeing" -

16 6 4 0
The image contains four bar graphs labeled A to D. A and C show 'Medical cost associated with AF' by sex and rurality, respectively. B and D show 'Productivity loss cost associated with AF' by sex and rurality, respectively. Each graph compares different cost factors.

The image contains four bar graphs labeled A to D. A and C show 'Medical cost associated with AF' by sex and rurality, respectively. B and D show 'Productivity loss cost associated with AF' by sex and rurality, respectively. Each graph compares different cost factors.

Among privately insured working-age US employees, #AtrialFibrillation was associated with $11,393 excess annual medical costs—mainly from outpatient care—and $840 greater productivity losses per person, affirming substantial economic burden.

ja.ma/4kGJpPS

0 0 0 0
Post image

Atrial Fibrillation care differs across regions and clinical settings.
The iCARDIO Global Survey on AF is now live and invites physicians to share real-world perspectives.
Anonymous. 10 minutes.
icardioalliance.org/surveys/

#cardiosky #medsky #AtrialFibrillation #Cardiology #GlobalGuidelines

0 0 0 0

😊 Follow our Cardiology & Heart Health starter package! 🫀

(scientists, research projects, hospitals, university departments, journals, companies, organisations & patient groups)

👉 go.bsky.app/TxzoAP1

#AtrialFibrillation #AFib #AFBurden #cardiology #HeartHealth #HeartFailure #CardioSky #CardioNews

3 3 0 0
Post image

☺️ Our interactive, successful, and fun #KickoffMeeting in #Amsterdam was wrapped up with democratic elections of important advisory boards & a motivating conclusion by Paulus Kirchhof & Christiana Krammer. Until next time!

#AF #AFib #AtrialFibrillation #arrhythmia #AFBurden #cardiosky #HeartHealth

4 2 0 0
Video

Productive breakout sessions by WP5 & WP8 researchers at our #KickoffMeeting resulted in increased awareness of the key technological + scientific challenges and decisions on how to tackle them!

We win if we can avert #HeartFailure!🫀😎

#AF #AFib #AtrialFibrillation #AI #explainableAI #HeartRhythm

4 2 0 0
Video

History lesson on #electrocardiography #ECGs in Prof. Fu Siong Ng’s talk!
🫀🩺😅

👉 WP8 - Predictors of no/low, intermediate, and high #AFBurden in patients: pathways for targeted #HeartRhythm monitoring (WP8 lead: Prof. Barbara Casadei
from @imperialcollegeldn.bsky.social)

#AFib #AtrialFibrillation

5 2 0 0
Two graphs compare bleeding with abelacimab vs. rivaroxaban. Graph A: bar graph shows incidence rate per 100 patient-years stratified by age. Graph B: probability of major bleeding vs. age for rivaroxaban and abelacimab pooled dose.

Two graphs compare bleeding with abelacimab vs. rivaroxaban. Graph A: bar graph shows incidence rate per 100 patient-years stratified by age. Graph B: probability of major bleeding vs. age for rivaroxaban and abelacimab pooled dose.

Among older patients with #AtrialFibrillation, abelacimab reduced major or clinically relevant bleeding vs rivaroxaban, with a greater absolute risk reduction in those aged ≥75 years. bit.ly/4alEy1P

0 1 0 0
Post image

🫀 Work package 6 (WP6) leader, Dr. med. Nina Becher from UKE, Hamburg, points out that #AFib assessment differs substantially across #CIEDs (pacemakers, #ICDs, implantable
loop recorders)!

👉 WP6 topic: “Standards for #AtrialFibrillation burden reporting by cardiac #implantable electronic devices”

3 2 0 0
Post image

⏳ Early interaction 📆 with the European Medicines Agency #EMA is key for proper exploitation + real-life regulatory impact of our @ihieurope.bsky.social funded project - based on advice from project leader Mirko de Melis and Acesion Pharma consortium members.

#AF #AtrialFibrillation #AFib #AFBurden

3 2 0 0